The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has received confirmation that its Prospera Lung donor-derived ...

A machine learning–based multidimensional model integrating clinical, radiomics, and cell-free DNA methylation biomarkers for the classification of pulmonary nodules. This is an ASCO Meeting Abstract ...

Lung cancer is the third most common cancer and the leading cause of cancer-related death in the United States. Two Main Types: Small cell lung cancer: 5-year overall survival (OS) = 7% Non-small cell ...

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically ...

The 2021 USPSTF lung cancer screening recommendations have broadened; however, these guidelines have not been compared with other criteria or evaluated for sensitivity and specificity differences by ...

Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodules Lung cancer is the leading cause of cancer death worldwide. Lung nodules are ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.